Table: begin end state 1 12 non-cytoplasmic 13 42 transmembrane 43 53 cytoplasmic 54 75 transmembrane 76 102 non-cytoplasmic 103 127 transmembrane 128 134 cytoplasmic 135 156 transmembrane 157 161 non-cytoplasmic 162 181 transmembrane 182 192 cytoplasmic 193 216 transmembrane 217 254 non-cytoplasmic 255 278 transmembrane 279 314 cytoplasmic 315 338 transmembrane 339 350 non-cytoplasmic 351 374 transmembrane 375 380 cytoplasmic 381 403 transmembrane 404 409 non-cytoplasmic 410 439 transmembrane 440 459 cytoplasmic 460 483 transmembrane 484 500 non-cytoplasmic
Input: >WP_086511815.1 NCBI__GCF_002151265.1:WP_086511815.1 MQGFATSLTFSNILAALVGAGLGIIVGAIPGLGSVTGIALLLPLTFQMDPITGIIMLGAL YYGCMYGGSYSAILLNIPGDAPAVVTSLDGYPLSQQGHGGKALFTANISSFIGGTVGIIM LTFMGPILAHVGLMFGPAEVAALILLALCSIGWLLGDNPLKGLISTFIGVMLATIGIGTA FGQPRFTFDSMYLLNGISFIPLVIGMFGFSQVLVMMVNRVDPSAKGLSGRLGLKESLLDR KEALSILPVSLRSGVLGNLVGILPGAGATTGSFLSYVLEKKVGRNGDELGKGRIQGVAAS EAGNNAAAAGSFAPLLSLGIPGSGTAAVLLGGLMMWGLQPGPLLFQNNPDFVWGLISSMY LGNVMAVLAALAIIPFLVKLLLIPASIMIPVIAVVCVVGSYSVNNSMFDVWFMLGAGVVA FFMTAARYPIAPLLLAFVLTPRLETSLRQALDISRGDPMIFLRSPIAATLLTLILLFVLY PLAKRLFMTVRRRGHKAAAE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server